Cannabis is creeping further into mainstream investing. Trulieve (NYSE: TRLV) appears on FTSE Russell's preliminary list of additions to the Russell 3000 Index, The Marijuana Herald reports, citing The Dales Report. An update to the story adds that Glass House Brands also made the preliminary list.
The Russell 3000 tracks roughly 3,000 of the largest U.S. public companies. If Trulieve's spot is finalized, it takes effect after markets close on Dec. 11, with trading under the new lineup starting Dec. 14. Trulieve is expected to land in the small-cap Russell 2000, which index funds follow, so inclusion could bring in buying from passive funds. FTSE Russell will update the lists on Nov. 20, Nov. 27 and Dec. 4.
This builds on a big year for the company. Trulieve listed on the New York Stock Exchange on June 10 and joined several S&P indexes in September, after the federal move in April put state-licensed medical marijuana in Schedule III. It reported $230 million in third-quarter revenue and runs 208 dispensaries.
What it means for travelers: Nothing changes at the counter, but Trulieve is one of the biggest names you'll see in Florida's medical market. It's a sign the industry is getting more mainstream. As always, never drive after consuming.






